U.S. FDA staff: Swedish Match snus proposal raises questions

April 7 (Reuters) - A preliminary review by the U.S. Food and Drug Administration raised "concerns" as to whether Swedish Match AB's proposed change to warnings on its snus smokeless tobacco products adequately reflect the health risk.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.